Insights
Reform and rebellion in the trademark world
By AWA | Posted on August 12, 2013
This spring, the EU commission published their proposals for a reform of the Council Regulation (EC) No 207/2009 on the Community trade mark and the Directive 2008/95/EC to approximate the laws of the Member States relating to trade marks. An earlier version of the proposals had been leaked ahead of time, but by the time...
Tags: PTO
Don’t bring your invention on vacation!
By Vibeke Warberg Rohde | Posted on August 7, 2013
This week a Swedish inventor was forced to realize that it is not smart to bring you invention when going to Denmark on vacation. Particularly not when the invention involves a large battery and a lot of wires attached to a car and when planning to park in a public garage. The trip resulted in...
The Cooperative Patent Classification expands!
By Troels Peter Rørdam | Posted on August 5, 2013
The Cooperative Patent Classification (CPC), which has now been in active use for half a year, has now begun the very interesting procedure of expanding geographically speaking. Particularly, both the SIPO (China) and the KIPO (Korea) have signed a so-called memorandum of understanding to initiate the adoption of the CPC. For starters, both offices have...
Tags: CPC
Birthday musings: Designing design strategy
By AWA | Posted on July 16, 2013
Earlier this year, the community design celebrated its tenth birthday. On 1 April 2003, the first community design was registered in Alicante and since then more than 690,000 designs have been registered. The yearly filings increase by a rate of no less than 78,000 a year. I think it’s fair to say that the community...
The dark side of the Internet
By AWA | Posted on July 12, 2013
On Friday the 14 June 2013 we participated in a seminar arranged by the Danish PTO in corporation with the Confederation of Danish Industry on the topic “IP infringements online”. The seminar aimed at discussing how to protect against infringement of one’s IP-rights on the Internet, and moreover a discussion of counterfeit, its extent and...
Filed under: Insights
An attempt to clarify what an embryo is
By Joanna Applequist | Posted on July 1, 2013
What is really meant by the term ”human embryo” as used in Article 6(2)(c) of the Biotech Directive (98/44/EC)? Are parthenotes to be considered as embryos and what is meant by “capable of commencing the process of development to a human being”? Following an appeal by International Stem Cell Corporation (“ISCC”) against a decision that...
Tags: Article 6(2)(c) of Directive 98/44/EC, embryo, Human embryo
Myriad patent claims on breast cancer genes invalidated by US Supreme Court
By Niklas Mattsson | Posted on June 14, 2013
In a decision on 13 June, the highest court of the USA, the US Supreme Court, said the final word in the highly publicized “gene patent” case involving Myriad Genetics. The decision is available here. See our previous reports on this case here, here and here. In brief, a group of plaintiffs wanted the courts...
DK-US Patent Prosecution Highway agreement version 2.0
By Troels Peter Rørdam | Posted on June 3, 2013
Patent Prosecution Highway agreement version 2.0 between the DKPTO and the USPTO Effective from today, 3 June 2103, the PPH agreement between The Danish Patent and Trademark Office (DKPTO) and The US Patent and Trademark Office (USPTO) has been upgraded to what the DKPTO aptly calls a “PPH-agrement version 2.0”. With the PPH agreement version...
Tags: DKPTO, patent application, patent prosecution highway, USPTO
Beer lovers sue for trademark dilution
By AWA | Posted on April 26, 2013
Trademarks are, among other things, a guarantee for a certain level of quality. If the quality slips, the consumers may go for a different, competing product. But sometimes consumers seem to stick to their favorites. An unusual lawsuit has been filed in the US, where consumers have filed a $5 million class action against Anheuser-Busch. The...
Tags: Anheuser-Busch
India’s Supreme Court rejects patent plea by Novartis for the cancer drug Glivec
By Jeanette Jakobsson | Posted on April 18, 2013
For years, India did not offer any patent protection for chemical compounds, but was obliged to do this after joining the World Trade Organization. In 2005, the patent protection act therefore was amended to also include such compounds, but only if they proved significant clinical efficacy enhancements over already patented compounds, Section 3(d) of the Indian...
Recent contributors
Partner, European Patent Attorney, Certified Danish Patent Agent
Partner, Attorney at Law, Business Area Manager
Associate, Attorney at Law, European Trademark and Design Attorney
Senior Associate, Patents
Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative
Partner, Attorney at Law, Group Vice President